Biosante Pharmaceuticals Inc. (BPAX) Stock Quote

Stock Web

Detailed Quote for Biosante Pharmaceuticals Inc. (BPAX)

close 52 Week Information

52 Week High

May 03,2010

Close: 2.50

52 Week Low

August 31,2010

Close: 1.29

Today

Last Price
1.38

Change $
0.02

Change %
1.43%

Tick

Bid
1.38

Bid Size
1000

Ask
1.39

Ask Size
1700

Open
1.42

High
1.42

Low
1.37

Prev Close
1.40

Last Trade
10:57

Volume
111.81 k

52 Wk Hi
2.50

52 Wk Low
1.29

Market Cap
97.71 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
70,802,894

EPS (TTM)
-1.44

PE Ratio
N/A

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for Biosante Pharmaceuticals Inc. (BPAX)

Sector News | Topic News

News for BPAX

Thu, Aug 12, 2010

4:15 PM

BioSante Pharmaceuticals Reports Second Quarter 2010 Financial Results - Business Wire

Tue, Jul 13, 2010

7:55 AM

BioSante Pharmaceuticals Announces Initiation of LibiGel(R) Study to Evaluate its Effect on Cognitive Function in Women - Business Wire

Wed, Jun 30, 2010

7:55 AM

BioSante Pharmaceuticals Announces Positive Clinical Results in Pill-Plus(TM) Oral Contraceptive Study - Business Wire

Mon, Jun 28, 2010

8:01 AM

BioSante Pharmaceuticals Added to Russell 3000(R) Index - Business Wire

Wed, Jun 23, 2010

5:00 PM

BioSante Pharmaceuticals Closes $15 Million Registered Direct Offering to Fund LibiGel(R) for Female Sexual Dysfunction - Business Wire

Tue, Jun 22, 2010

12:30 PM

The Michael J. Fox Foundation Awards $2.5 Million to Support Ceregene's New Phase 2 Neurturin Clinical Study for Parkinson's Disease - PR Newswire

Mon, Jun 21, 2010

9:55 AM

BioSante Pharmaceuticals to Raise $15 Million in Registered Direct Offering - Business Wire

9:05 AM

BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Clinical Program - Business Wire

8:45 AM

BioSante Pharmaceuticals Says FDA Advisory Committee Recommendation Against Flibanserin has No Impact on LibiGel(R) - Business Wire

Fri, Jun 18, 2010

7:55 AM

BioSante Pharmaceuticals, Inc. To Present LibiGel(R) Safety Update at ENDO Annual Meeting - Business Wire

Mon, Jun 07, 2010

7:59 AM

BioSante Announces FDA Orphan Drug Designation for GVAX Chronic Myeloid Leukemia Cancer Vaccine - Business Wire

1:15 AM

BioSante Pharmaceuticals, Inc. to Present at the Annual Needham Healthcare Conference - Business Wire

Fri, Jun 04, 2010

11:47 AM

BioSante Pharmaceuticals, Inc. To Present at the Annual Needham Healthcare Conference - Business Wire

Wed, Apr 28, 2010

7:18 AM

Ceregene has Initiated a New Phase 1/2 Trial Of CERE-120 for Parkinson's Disease - PR Newswire

Fri, Mar 12, 2010

6:50 AM

Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by Beacon Equity - Globe Newswire

Mon, Feb 22, 2010

9:01 AM

Skymark Research Initiates Independent Research Coverage on BioSante Pharmaceuticals, Inc. - Globe Newswire

8:08 AM

BioSante's (Nasdaq: BPAX) CEO Pleased With the Progress of LibiGel(R) Phase III Clinical Development Program - Marketwire

Thu, Dec 03, 2009

12:27 PM

Nearly 100 Companies to Present at The OneMedForum 2010 Finance Conference - Marketwire

Thu, Oct 08, 2009

10:25 AM

25 Companies Already Committed to Present at the OneMedForum 2010 Finance Conference - Marketwire

Tue, Aug 19, 2008

7:50 AM

RedChip Will Ring the NASDAQ Closing Bell During Its Emerging Markets Investor Conference Aug. 21st - Globe Newswire

More News for BPAX >>

Tags for Biosante Pharmaceuticals Inc.

Research stocks or mutual funds related to Biosante Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to BPAX. The keywords below have been associated to BPAX by either user submission or electronic means.

herbal menopause dhea hormone symptoms of menopause testosterone menopause increase libido female menopause know menopause women's libido pharmaceuticals companies thyroid hormone replacement decreased libido women women libido dupont pharmaceuticals decreased libido Biological Products estrogen replacement therapy womens libido woman libido human growth hormone pharma license libido sexuality female progesterone cream drug delivery women menopause pharmaceutical sales hormones aphrodisiacs for women testosterone patch menopause hormone replacement therapy no libido pharma Testosterone replacement therapy pharmaceutical development loss of libido pharmaceutical reports pharmaceutical magazine hormones female Drugs women testosterone natural hrt testosterone women low female enhancement bioidentical hormone replacement therapy menopause treatment female libido drug testosterone female low elan pharmaceutical pharmaceutical sale menopause relief

Biosante Pharmaceuticals Inc. (BPAX) Stock Quote

Bookmark With: